TY - JOUR
T1 - Patients with IBD Want to Talk About Sleep and Treatments for Insomnia with Their Gastroenterologist
AU - Salwen-Deremer, Jessica K.
AU - Godzik, Cassandra M.
AU - Jagielski, Christina H.
AU - Siegel, Corey A.
AU - Smith, Michael T.
N1 - Funding Information:
This work was supported by JSD’s internal funding from the Departments of Psychiatry and Medicine (Section of Gastroenterology & Hepatology) at Dartmouth–Hitchcock/Geisel School of Medicine at Dartmouth. CMG is a postdoctoral research fellow with the Northern New England Post-Doctoral Primary Care Research Training Program. Health Resources and Services Administration (HRSA): Grant—HRSA T32 HP32520. She completed work on this manuscript as part of her T32.
Publisher Copyright:
© 2023, The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
PY - 2023/6
Y1 - 2023/6
N2 - Background and Aims: Poor sleep may be prospectively associated with worse disease course in inflammatory bowel disease (IBD). Chronic insomnia is the most common cause of poor sleep complaints in IBD and is theorized to be maintained by dysfunctional thoughts and behavioral patterns. However, data characterizing patterns specific to insomnia in IBD are lacking. Understanding the nuances of insomnia and patients’ preferences for treatment is critical for addressing this significant comorbidity in IBD. Methods: We conducted an anonymous, mixed-method online survey of people with IBD and asked questions about sleep patterns, thoughts, and behaviors related to sleep, treatment preferences, and barriers to treatment. Results: 312 participants (60.9% Crohn’s, 66.3% women, mean age of 48.62 years) were included in this study. Participants with insomnia were significantly more concerned about the consequences of sleep loss, felt more helpless about their sleep, and were more likely to engage in behaviors known to perpetuate insomnia (e.g., spending time in bed in pain; ps ≤ 0.001) than those without insomnia. 70.3% of participants were interested in discussing sleep as part of IBD care, 63.5% were interested in receiving sleep recommendations from their gastroenterologist, and 84.6% of those with insomnia were interested in participating in sleep treatments. Conclusion: Participants with IBD and insomnia are interested in treatment and reported patterns that can be targeted in Cognitive Behavioral Therapy for Insomnia, as opposed to traditional sleep hygiene guidelines. Additionally, people with insomnia engaged in several sleep-interfering behaviors related to pain. Clinical trials that target insomnia in people with IBD should include pain management in the intervention.
AB - Background and Aims: Poor sleep may be prospectively associated with worse disease course in inflammatory bowel disease (IBD). Chronic insomnia is the most common cause of poor sleep complaints in IBD and is theorized to be maintained by dysfunctional thoughts and behavioral patterns. However, data characterizing patterns specific to insomnia in IBD are lacking. Understanding the nuances of insomnia and patients’ preferences for treatment is critical for addressing this significant comorbidity in IBD. Methods: We conducted an anonymous, mixed-method online survey of people with IBD and asked questions about sleep patterns, thoughts, and behaviors related to sleep, treatment preferences, and barriers to treatment. Results: 312 participants (60.9% Crohn’s, 66.3% women, mean age of 48.62 years) were included in this study. Participants with insomnia were significantly more concerned about the consequences of sleep loss, felt more helpless about their sleep, and were more likely to engage in behaviors known to perpetuate insomnia (e.g., spending time in bed in pain; ps ≤ 0.001) than those without insomnia. 70.3% of participants were interested in discussing sleep as part of IBD care, 63.5% were interested in receiving sleep recommendations from their gastroenterologist, and 84.6% of those with insomnia were interested in participating in sleep treatments. Conclusion: Participants with IBD and insomnia are interested in treatment and reported patterns that can be targeted in Cognitive Behavioral Therapy for Insomnia, as opposed to traditional sleep hygiene guidelines. Additionally, people with insomnia engaged in several sleep-interfering behaviors related to pain. Clinical trials that target insomnia in people with IBD should include pain management in the intervention.
KW - Crohn’s disease
KW - Inflammatory bowel disease
KW - Pain
KW - Psychogastroenterology
KW - Sleep
KW - Ulcerative colitis
UR - http://www.scopus.com/inward/record.url?scp=85148913014&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85148913014&partnerID=8YFLogxK
U2 - 10.1007/s10620-023-07883-8
DO - 10.1007/s10620-023-07883-8
M3 - Article
C2 - 36840812
AN - SCOPUS:85148913014
SN - 0163-2116
VL - 68
SP - 2291
EP - 2302
JO - Digestive diseases and sciences
JF - Digestive diseases and sciences
IS - 6
ER -